LAUSR

Leptospirosis is a potentially life‐threatening zoonosis caused by pathogenic Leptospira and for rapid diagnostics, direct detection is desirable. LipL32 protein is the most suitable biomarker for direct detection. DNA aptamers are sought to be generated against LipL32 by Systemic Evolution of Ligands via Exponential Enrichment (SELEX). LepDapt‐5a is the most potent aptamer candidate among all the candidates, as determined by direct Enzyme‐linked Aptasorbent Assay (ELASA). LepDapt‐5a was predicted to form a G‐quadruplex structure as predicted by QGRS Mapper and validated experimentally by direct ELASA. The diagnostic potential of the aptamer was further tested on a direct and sandwich ELASA platform. A LOD of 106 mL‐1 and 105 mL‐1 were estimated by direct and sandwich ELASA platforms, respectively, which are within the range associated with leptospiremia levels. The dot blot assay developed was able to attain a LOD of 104 CFU mL−1 against pathogenic Leptospira, which is also within the leptospiremia level. This is the first‐ever DNA aptamer and hybrid‐heterodimeric aptamer constructed against LipL32. The diagnostic potentiality of the LepDapt‐5a DNA aptamer was proven on three major diagnostic platforms, which are direct ELASA, sandwich ELASA, and aptamer‐based dot assay.